The FDA has received reports of serious adverse events which describe medication dosing inaccuracies and other mechanical problems with the pump that have led to patient injury and death. The Food and ...

Iradimed picked up an FDA nod for its MRI-compatible intravenous infusion pump system, which enables patients who can’t be disconnected from IV medication to undergo MRI scanning. The company will now ...

Iradimed Corporation announced that it has received FDA 510(k) clearance for its next-generation MRidium® 3870 IV Infusion Pump System, making it the only supplier of non-magnetic MRI-compatible ...

Pending FDA approval, the upgraded Prometra Implantable Pump System for the targeted delivery of pain medication will feature MRI compatibility, Flowonix CEO Steve Adler told FierceDrugDelivery in an ...

The US Food and Drug Administration (FDA) has received reports of serious adverse events, including patient injury and death, associated with the use of implantable infusion pumps in the magnetic ...

iRadimed, which makes non-magnetic MRI-safe IV infusion pumps, raised $13 million by offering 2.0 million shares at $6.25, above the $5 to $6 range. iRadimed will list on the NASDAQ under the symbol ...

Flowonix, maker of the implantable Prometra infusion pump for chronic pain patients, announced that it has raised $40 million in debt and equity financing, led by private equity fund Élevage Capital ...

Please provide your email address to receive an email when new articles are posted on . The FDA recently issued a statement addressing reports of serious adverse events, such as injury or death, ...